Ashley Eheim

1.7k total citations
11 papers, 429 citations indexed

About

Ashley Eheim is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Ashley Eheim has authored 11 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Infectious Diseases and 3 papers in Epidemiology. Recurrent topics in Ashley Eheim's work include Liver physiology and pathology (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Sphingolipid Metabolism and Signaling (2 papers). Ashley Eheim is often cited by papers focused on Liver physiology and pathology (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Sphingolipid Metabolism and Signaling (2 papers). Ashley Eheim collaborates with scholars based in Germany, United States and Norway. Ashley Eheim's co-authors include Ralf Lesche, Krzysztof Brzezinka, Andrea Haegebarth, Marcus Bauser, Claudia Merz, Iain H. McKillop, Elizabeth Brandon‐Warner, Laura W. Schrum, Tracy L. Walling and Sven Christian and has published in prestigious journals such as Hepatology, Cancer Research and European Journal of Cancer.

In The Last Decade

Ashley Eheim

11 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashley Eheim Germany 9 312 123 68 48 46 11 429
Ziqi Cheng China 10 178 0.6× 105 0.9× 64 0.9× 28 0.6× 18 0.4× 15 323
Suk-Young Yoo United States 10 235 0.8× 83 0.7× 36 0.5× 122 2.5× 37 0.8× 12 387
Hugues Bernard United States 10 296 0.9× 80 0.7× 63 0.9× 93 1.9× 18 0.4× 13 408
François Hermetet France 12 223 0.7× 88 0.7× 40 0.6× 50 1.0× 33 0.7× 23 398
Zhuoxin Cheng China 14 280 0.9× 159 1.3× 27 0.4× 156 3.3× 41 0.9× 20 557
Yaqiu Zheng China 12 224 0.7× 102 0.8× 82 1.2× 75 1.6× 6 0.1× 21 425
Yoshihiro Wakazono Japan 11 263 0.8× 139 1.1× 35 0.5× 103 2.1× 46 1.0× 23 522
Patricia Macanas-Pirard United Kingdom 9 114 0.4× 40 0.3× 48 0.7× 87 1.8× 46 1.0× 13 387
Yoshihiko Shibayama Japan 11 239 0.8× 144 1.2× 23 0.3× 139 2.9× 19 0.4× 26 445
Juan Esquivel United States 6 285 0.9× 61 0.5× 220 3.2× 71 1.5× 15 0.3× 7 457

Countries citing papers authored by Ashley Eheim

Since Specialization
Citations

This map shows the geographic impact of Ashley Eheim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley Eheim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley Eheim more than expected).

Fields of papers citing papers by Ashley Eheim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashley Eheim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley Eheim. The network helps show where Ashley Eheim may publish in the future.

Co-authorship network of co-authors of Ashley Eheim

This figure shows the co-authorship network connecting the top 25 collaborators of Ashley Eheim. A scholar is included among the top collaborators of Ashley Eheim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashley Eheim. Ashley Eheim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Siegel, Franziska, Stephan Siegel, Gizem Karsli-Uzunbas, et al.. (2022). BAY 2927088: The first non-covalent, potent, and selective tyrosine kinase inhibitor targeting EGFR exon 20 insertions and C797S resistance mutations in NSCLC. European Journal of Cancer. 174. S9–S10. 6 indexed citations
2.
Brzezinka, Krzysztof, Ekaterina Nevedomskaya, Ralf Lesche, et al.. (2020). Characterization of the Menin-MLL Interaction as Therapeutic Cancer Target. Cancers. 12(1). 201–201. 34 indexed citations
3.
Brzezinka, Krzysztof, Ekaterina Nevedomskaya, Ralf Lesche, et al.. (2019). Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia. Journal of Hematology & Oncology. 12(1). 66–66. 27 indexed citations
4.
Christian, Sven, Claudia Merz, Laura Evans, et al.. (2019). The novel dihydroorotate dehydrogenase (DHODH) inhibitor BAY 2402234 triggers differentiation and is effective in the treatment of myeloid malignancies. Leukemia. 33(10). 2403–2415. 146 indexed citations
5.
Eheim, Ashley, Sven Christian, Hanna Meyer, et al.. (2019). Abstract 3597: BAY 2402234: Preclinical evaluation of a novel, selective dihydroorotate dehydrogenase (DHODH) inhibitor for the treatment of diffuse large B-cell lymphoma (DLBCL). Cancer Research. 79(13_Supplement). 3597–3597. 1 indexed citations
6.
Quanz, Maria, Eckhard Bender, Charlotte Kopitz, et al.. (2018). Preclinical Efficacy of the Novel Monocarboxylate Transporter 1 Inhibitor BAY-8002 and Associated Markers of Resistance. Molecular Cancer Therapeutics. 17(11). 2285–2296. 82 indexed citations
7.
Li, Ting, Ashley Eheim, Sabine Klein, et al.. (2014). Novel role of nuclear receptor rev-erbα in hepatic stellate cell activation: Potential therapeutic target for liver injury. Hepatology. 59(6). 2383–2396. 43 indexed citations
8.
Simo, Kerri A., Erin M. Hanna, Jacob H. Swet, et al.. (2013). Altered lysophosphatidic acid (LPA) receptor expression during hepatic regeneration in a mouse model of partial hepatectomy. HPB. 16(6). 534–542. 12 indexed citations
9.
Eheim, Ashley, Daša Medříková, & Stephan Herzig. (2013). Immune cells and metabolic dysfunction. Seminars in Immunopathology. 36(1). 13–25. 19 indexed citations
10.
Brandon‐Warner, Elizabeth, Ashley Eheim, David Foureau, et al.. (2012). Silibinin (Milk Thistle) potentiates ethanol-dependent hepatocellular carcinoma progression in male mice. Cancer Letters. 326(1). 88–95. 31 indexed citations
11.
Sokolov, Eugene P., Ashley Eheim, Wolfgang Ahrens, et al.. (2012). Lysophosphatidic acid receptor expression and function in human hepatocellular carcinoma. Journal of Surgical Research. 180(1). 104–113. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ziqi Cheng Breakdown of academic impact, for papers by Suk-Young Yoo Breakdown of academic impact, for papers by Hugues Bernard Breakdown of academic impact, for papers by François Hermetet Breakdown of academic impact, for papers by Zhuoxin Cheng Breakdown of academic impact, for papers by Yaqiu Zheng Breakdown of academic impact, for papers by Yoshihiro Wakazono Breakdown of academic impact, for papers by Patricia Macanas-Pirard Breakdown of academic impact, for papers by Yoshihiko Shibayama Breakdown of academic impact, for papers by Juan Esquivel
Rankless by CCL
2026